Eldawy, H., Elrehany, M., Bekhit, A., Thabet, K. (2025). Interstitial lung disease: A review. Journal of Advanced Biomedical and Pharmaceutical Sciences, 8(1), 1-6. doi: 10.21608/jabps.2024.320282.1222
Hanan Omar Eldawy; Mahmoud Elrehany; Amany Bekhit; Khaled Thabet. "Interstitial lung disease: A review". Journal of Advanced Biomedical and Pharmaceutical Sciences, 8, 1, 2025, 1-6. doi: 10.21608/jabps.2024.320282.1222
Eldawy, H., Elrehany, M., Bekhit, A., Thabet, K. (2025). 'Interstitial lung disease: A review', Journal of Advanced Biomedical and Pharmaceutical Sciences, 8(1), pp. 1-6. doi: 10.21608/jabps.2024.320282.1222
Eldawy, H., Elrehany, M., Bekhit, A., Thabet, K. Interstitial lung disease: A review. Journal of Advanced Biomedical and Pharmaceutical Sciences, 2025; 8(1): 1-6. doi: 10.21608/jabps.2024.320282.1222
1Department of biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt.
2Department of Biochemistry, Faculty of Pharmacy, Deraya University, Minia, Egypt.
3Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt
41Department of biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt.
Abstract
Interstitial lung disease (ILD) is a term used to describe various lung conditions characterized by inflammation and, less commonly, fibrosis. Idiopathic pulmonary fibrosis is one of the most lethal ILDs, exhibiting a broad spectrum of clinical manifestations. Common symptoms of ILD are dyspnea (shortness of breath), coughing, abnormalities in gas exchange, reduced lung volumes, hypoxemia, and, in severe cases, respiratory failure. A preexisting medical condition or environmental variables may set off an ILD. Many ILDs have treatment options or even a cure, depending on the subtypes. Lung transplantation, however, is the sole curative choice in some instances. Evidence shows that common and unusual genetic variants can influence various ILDs.
View on SCiNiTO
Top